Daily Inverse VIX ST ETN Velocityshares (XIV) 28.66

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Daily Inverse VIX ST ETN Velocityshares (XIV) 28.66 $XIV

Watch for VelocityShares Daily Inverse VIX ST ETN to Potentially Rebound After Falling 17.92% Yesterday
Comtex SmarTrend(R) - Mon Aug 24, 4:40PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $22.88 to a high of $34.37. Yesterday, the shares fell 17.9%, which took the trading range below the 3-day low of $35.98 on volume of 81.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 28.66 (+2.56)

Bull Chart of the Day: VelocityShares Daily Inverse VIX ST ETN
at The Street - Mon Aug 24, 9:55AM CDT
But don't get overextended too quickly.
XIV: 28.66 (+2.56)

After Yesterday's Decline of 16.36%, VelocityShares Daily Inverse VIX ST ETN Offers Investors Better Value
Comtex SmarTrend(R) - Fri Aug 21, 3:48PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $35.98 to a high of $41.89. Yesterday, the shares fell 16.4%, which took the trading range below the 3-day low of $42.69 on volume of 55.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 28.66 (+2.56)

VelocityShares Daily Inverse VIX ST ETN Set to Possibly Pullback After Yesterday's Rally of 1.28%
Comtex SmarTrend(R) - Mon Aug 17, 3:58PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $46.91 to a high of $48.51. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $48.44 on volume of 9.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XIV: 28.66 (+2.56)

Watch for VelocityShares Daily Inverse VIX ST ETN to Potentially Rebound After Falling 4.51% Yesterday
Comtex SmarTrend(R) - Tue Aug 11, 3:50PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $46.24 to a high of $48.24. Yesterday, the shares fell 4.5%, which took the trading range below the 3-day low of $46.25 on volume of 18.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 28.66 (+2.56)

Look for Shares of VelocityShares Daily Inverse VIX ST ETN to Potentially Rebound after Yesterday's 3.52% Sell Off
Comtex SmarTrend(R) - Thu Aug 06, 4:28PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $46.25 to a high of $48.90. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of $46.80 on volume of 17.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 28.66 (+2.56)

Watch for VelocityShares Daily Inverse VIX ST ETN to Potentially Pullback After Gaining 1.50% Yesterday
Comtex SmarTrend(R) - Mon Aug 03, 3:52PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $46.80 to a high of $48.88. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $48.74 on volume of 14.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XIV: 28.66 (+2.56)

3 ETFs the Smartest Investors Are Buying
Selena Maranjian, Dan Caplinger, and Jason Hall, The Motley Fool - Motley Fool - Thu Jul 30, 8:18AM CDT
Photo:  Got Credit Part stock-like, part-mutual-fund-like, exchange-traded funds have been exploding in popularity over the past two decades. The Investment Company Institute estimates that, as of the end of 2014, there were 1,411 index-based and...
VT: 56.85 (+1.62), VUG: 102.20 (+3.94), XIV: 28.66 (+2.56)

After Yesterday's Decline of 2.92%, VelocityShares Daily Inverse VIX ST ETN Offers Investors Better Value
Comtex SmarTrend(R) - Fri Jul 24, 4:28PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $45.47 to a high of $48.20. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $46.78 on volume of 19.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 28.66 (+2.56)

VelocityShares Daily Inverse VIX ST ETN Rises 9.67% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Jul 13, 3:52PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $41.83 to a high of $43.93. Yesterday, the shares gained 9.7%, which took the trading range above the 3-day high of $40.37 on volume of 21.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XIV: 28.66 (+2.56)

Volatility Surges 35% On Grexit Fears: It's Time To (Start) Shorting The VIX
Force Majeure - at Seeking Alpha - Wed Jul 01, 3:18AM CDT

VXUP: 1.47 (-0.21), TVIX: 11.94 (-2.67), SPY: 194.46 (+7.19), VXX: 24.12 (-2.46), ZIV: 42.20 (+2.20), VXZ: 12.03 (-0.65), VXDN: 1.99 (+0.21), XIV: 28.66 (+2.56)

History Says Shorting Volatility Is The Right Move Here
Josh Arnold - at Seeking Alpha - Tue Jun 30, 7:55AM CDT

VXX: 24.12 (-2.46), XIV: 28.66 (+2.56)

Are HFTs Responsible For Low Market Volatility?
Cam Hui, CFA - at Seeking Alpha - Sat Jun 27, 7:30AM CDT
I received a number of thoughtful responses from my last post about falling equity volatility (see Will the quants blow up the markets again? ). One of the themes that was repeated several times in the comments pointed to HFT algos as a possible...
VXUP: 1.47 (-0.21), TVIX: 11.94 (-2.67), VXX: 24.12 (-2.46), IVOP: 38.26 (unch), UVXY: 54.56 (-11.72), XIV: 28.66 (+2.56), SVXY: 56.02 (+4.86), SPY: 194.46 (+7.19), DIA: 162.66 (+6.17), VIIX: 32.58 (-3.33), VXDN: 1.99 (+0.21), XXV: 38.13 (-0.09), VIXY: 16.01 (-1.67)

Summer Correction On The Horizon
Carbide Capital Inc. - Seeking Alpha - Fri Jun 26, 3:02PM CDT
As summer gets into full swing and markets continue to obsess over the Fed and Greece, we are seeing some interesting dynamics occur. On the one hand, economic data has been improving in the United States. Consumer spending just had its largest...
TVIX: 11.94 (-2.67), SPY: 194.46 (+7.19), VXX: 24.12 (-2.46), IYT: 137.95 (+3.81), XIV: 28.66 (+2.56)

VelocityShares Daily Inverse VIX ST ETN Up 56.2% Since SmarTrend Uptrend Call (XIV)
Comtex SmarTrend(R) - Fri Jun 26, 11:21AM CDT
SmarTrend identified an Uptrend for VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) on February 23rd, 2015 at $31.02. In approximately 4 months, VelocityShares Daily Inverse VIX ST ETN has returned 56.16% as of today's recent price of $48.43.
XIV: 28.66 (+2.56)

Volatility vanishes from U.S. equities
Seeking Alpha - at Seeking Alpha - Tue Jun 23, 9:03AM CDT

VXUP: 1.47 (-0.21), TVIZ: 17.48 (-1.70), TVIX: 11.94 (-2.67), VIXM: 58.53 (-3.14), XVIX: 16.36 (unch), VXX: 24.12 (-2.46), IVOP: 38.26 (unch), UVXY: 54.56 (-11.72), VXZ: 12.03 (-0.65), CVOL: 0.75 (-0.23), XIV: 28.66 (+2.56), SVXY: 56.02 (+4.86), XVZ: 28.05 (-0.14), ZIV: 42.20 (+2.20), VIIX: 32.58 (-3.33), VXDN: 1.99 (+0.21), VIIZ: 16.73 (-0.72), XXV: 38.13 (-0.09), VIXY: 16.01 (-1.67)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 44

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 44

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 61

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 38

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 56

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 46

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 48

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Cemtrex's Stock Surge Sparks Interest in Leading Movers

Updated Category News Views 117

Cemtrex Experiences Notable Share Surge Shares of Cemtrex, Inc. CETX have seen a significant uptick amid pre-market trading. This boost comes on the heels of better-than-expected sales in the latest quarter, reporting an impressive $18.10 million in sales, surpassing the general analyst expectation of $16.39 million. This remarkable performance in sales has sparked...

Continue Reading
Exciting New PharmD-MBA Pathway Combines Pharmacy and Business

Updated Category News Views 193

Collaboration between Cal Poly Pomona and Western University In an exciting move, Cal Poly Pomona's Singelyn Graduate School of Business and Western University of Health Sciences have teamed up to create a groundbreaking pathway for aspiring healthcare professionals. This innovative PharmD-MBA program combines the fields of pharmacy and business, providing a unique...

Continue Reading
Kaskela Law Investigates Stock Misconduct in Stanley Black & Decker

Updated Category News Views 155

Overview of the Investigation by Kaskela Law LLC Kaskela Law LLC has announced an important investigation focused on Stanley Black & Decker, Inc. (NYSE: SWK) concerning allegations of potential securities fraud. This inquiry is primarily aimed at safeguarding the interests of long-term investors who hold shares in this well-known manufacturing company. Details Surrounding...

Continue Reading
Legend Biotech's Carvykti: A Leading Force in Cancer Treatment

Updated Category News Views 90

Redburn's Positive Outlook for Legend Biotech Recently, Redburn-Atlantic began covering Legend Biotech Corp. (NASDAQ: LEGN) with a favorable Buy rating and set a price target of $86.00 for the stock. This biotechnology company has made significant strides, particularly with the recent approval of its innovative product, Carvykti, designed for the treatment of multiple...

Continue Reading
Transforming the Anti-Obesity Drug Market for Future Success

Updated Category News Views 132

Global Anti-Obesity Drug Market Overview As global health concerns rise, the demand for anti-obesity drugs is surging. Recent reports estimate that the anti-obesity drug market will soar to USD 82.55 billion in the coming years. This impressive growth, fueled by an anticipated compound annual growth rate (CAGR) of 18.01%, signals a crucial moment for pharmaceutical...

Continue Reading